Literature DB >> 11086631

Benefits and pitfalls of cardiovascular risk assessment.

N R Poulter1.   

Abstract

One of the most important challenges facing modern preventative medicine is the problem of how best to identify and treat those at highest risk of developing cardiovascular disease, for whom appropriate management (ranging from lifestyle modification to therapeutic regimens) can improve both duration and quality of life. The use of risk assessment can contribute greatly to identifying those individuals who will benefit from risk-reducing interventions. However, assessment tools must always be used with care because some are not sufficiently accurate, while most systems are subject to an ageist bias because they do not take into account the benefits of long-term treatment or risk. Nonetheless, assessment techniques can provide a more logical approach to patient management, predict short-term benefits, and provide accurate data to substantiate a physician's clinical judgement.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086631     DOI: 10.1038/sj.jhh.1001071

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  3 in total

1.  The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999-2018.

Authors:  Fatemeh Koohi; Karim Kohansal; Marzieh Saei Ghare Naz; Somayeh Derakhshan; Fereidoun Azizi; Davood Khalili
Journal:  BMC Public Health       Date:  2022-03-28       Impact factor: 3.295

2.  Dietary diversity associated with risk of cardiovascular diseases among community-dwelling older people: A national health examination survey from Thailand.

Authors:  Chalobol Chalermsri; Shirin Ziaei; Eva-Charlotte Ekström; Weerasak Muangpaisan; Wichai Aekplakorn; Warapone Satheannopakao; Syed Moshfiqur Rahman
Journal:  Front Nutr       Date:  2022-09-08

3.  Chronic inflammation in psoriasis promotes visceral adiposity associated with noncalcified coronary burden over time.

Authors:  Aparna Sajja; Khaled M Abdelrahman; Aarthi S Reddy; Amit K Dey; Domingo E Uceda; Sundus S Lateef; Alexander V Sorokin; Heather L Teague; Jonathan Chung; Joshua Rivers; Aditya A Joshi; Youssef A Elnabawi; Aditya Goyal; Justin A Rodante; Andrew Keel; Julie E Alvarez; Benjamin Lockshin; Ronald Prussick; Evan Siegel; Martin P Playford; Marcus Y Chen; David A Bluemke; Joel M Gelfand; Nehal N Mehta
Journal:  JCI Insight       Date:  2020-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.